Pheno Therapeutics buys rights to potential remyelination drug
Drug Discovery World
JANUARY 12, 2023
Pheno Therapeutics has entered an agreement with UCB for the rights to develop, manufacture and commercialise a preclinical-stage programme of novel small molecules designed to promote remyelination. .
Let's personalize your content